Search

Your search keyword '"Tushuizen, Maarten E."' showing total 14 results
Start Over Author "Tushuizen, Maarten E." Publisher wiley
14 results on '"Tushuizen, Maarten E."'

1. A global survey of health care workers' awareness of non‐alcoholic fatty liver disease: The AwareNASH survey

Author

Driessen, Stan, primary, de Jong, Vivian D., additional, van Son, Koen C., additional, Klompenhouwer, Tatiana, additional, Colardelle, Yann, additional, Alings, Marco, additional, Moreno, Cristophe, additional, Anker, Stefan D., additional, Castro Cabezas, Manuel, additional, Holleboom, Adriaan G., additional, Grobbee, Diederick E., additional, and Tushuizen, Maarten E., additional

Published
2023
Full Text
View/download PDF

4. Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis

Author

Fischer, Susan E., primary, de Vries, Elsemieke S., additional, Tushuizen, Maarten E., additional, de Boer, Ynto S., additional, van der Meer, Adriaan J. P., additional, de Man, Robert A., additional, Brouwer, Johannes T., additional, Kuyvenhoven, Johan P., additional, Klemt‐Kropp, Michael, additional, Gevers, Tom J. G., additional, Tjwa, Eric T. T. L., additional, Kuiper, Edith M. M., additional, Verhagen, Marc A. M. T., additional, Friederich, Philip W., additional, and van Hoek, Bart, additional

Published
2023
Full Text
View/download PDF

6. Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques

Author

Theel, Willy, primary, Boxma‐de Klerk, Bianca M., additional, Dirksmeier‐Harinck, Femme, additional, van Rossum, Elisabeth F. C., additional, Kanhai, Danny A., additional, Apers, Jan, additional, van Dalen, Bas M., additional, de Knegt, Robert J., additional, Holleboom, Anthony G., additional, Tushuizen, Maarten E., additional, Grobbee, Diederick E., additional, Wiebolt, Janneke, additional, and Castro Cabezas, Manuel, additional

Published
2022
Full Text
View/download PDF

11. Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands

Author

van den Brand, Floris F., primary, van Nieuwkerk, Carin M. J., additional, Verwer, Bart J., additional, de Boer, Ynto S., additional, de Boer, Nanne K. H., additional, Mulder, Chris J. J., additional, Bloemena, Elisabeth, additional, Bakker, Christine M., additional, Vrolijk, Jan M., additional, Drenth, Joost P. H., additional, Tan, Adriaan C. I. T. L., additional, ter Borg, Frank, additional, ter Borg, Martijn J., additional, van den Hazel, Sven J., additional, Inderson, Akin, additional, Tushuizen, Maarten E., additional, and Bouma, Gerd, additional

Published
2018
Full Text
View/download PDF

14. Association between skeletal muscle index prior to liver transplantation and 1-year mortality posttransplant.

Author

Bot D, Klerks S, Leistra E, Tushuizen ME, and van Hoek B

Subjects
Humans, Muscle, Skeletal, Length of Stay, Retrospective Studies, Liver Transplantation adverse effects, Sarcopenia etiology, End Stage Liver Disease
Abstract

Background: Liver transplantation is the only curative therapy for end-stage liver disease (ESLD). Sarcopenia is often defined as the loss of muscle quantity (skeletal muscle index [SMI]), but muscle attenuation (MA), a surrogate marker of muscle quality, is also decreased in ESLD. We assessed pre-liver transplant SMI and MA and their association with posttransplant mortality, complications, and length of intensive care unit (ICU) and hospital stay., Methods: In 169 consecutive patients with ESLD who underwent a liver transplantation between 2007 and 2014, SMI and MA were measured on computed tomography scans at time of placement on the waiting list for liver transplantation. The primary outcome of interest was 1-year posttransplant mortality. Secondary posttransplantation outcomes of interest were complications within 30 days and length of stay in the ICU > 3 days and in the hospital >3 weeks. Logistic and Cox regression analyses were performed., Results: MA was associated with 1-year posttransplant mortality rate (hazard ratio=0.656, 95% CI=0.464-0.921, P = 0.015). The highest quartile of SMI had a lower odds for the total length of stay in the hospital lasting >3 weeks (odds ratio=0.211, 95% CI=0.061-0.733, P = 0.014). MA was associated with a prolonged ICU stay; this was, however, not statistically significant after adjustment for age, sex, and Model for ESLD score., Conclusion: Lower MA is associated with a longer length of ICU stay and 1-year mortality after liver transplantation, whereas low SMI was associated with a total length of hospital stay., (© 2023 The Authors. Journal of Parenteral and Enteral Nutrition published by Wiley Periodicals LLC on behalf of American Society for Parenteral and Enteral Nutrition.)

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results